altona Diagnostics announces leadership transition

New General Managers appointed

05-Jul-2024 - altona Diagnostics GmbH announces a leadership transition. Dr. Ulrich Spengler and Dr. Markus Hess, the current General Managers, are transferring the management responsibilities to Dr. Sönke Friedrichsen and Hans Kuhn. New leadership for a growing company Reflecting the development and expansion ...

Protecting art and passwords with biochemistry

New technology is based on a pool of one hundred million different DNA molecules and protects against counterfeiting

10-Apr-2024 - A new molecular test method helps to prove the authenticity of works of art. The new method could also help to make passwords secure against quantum computers. Instead of using algorithms, the method employs the polymerase chain reaction (PCR) and DNA sequencing. Security experts fear Q-​Day, the ...

Simplified screening of individual bacterial species in biosamples

Method saves time and costs when analysing complex microbiological samples

30-Mar-2023 - In medical research and diagnostics, the microbiome, i.e. the microbial colonisation of the intestine, is increasingly gaining attention. A stool sample can be used to precisely analyse the complex microbial ecosystem of the gut. There are basically two methods for this: traditional cultivation ...

Analyze proteins and protein interactions with hitherto unseen performance

Life-science startup Actome announces release of first commercial products

09-May-2022 - Actome has released the first commercial products to the EU market based on the Protein Interaction Coupling (PICO) Technology. The PICO assay kits for measuring proteins and protein interactions are available throughActome's online webshop. Actome GmbH is a life-science startup form Freiburg ...

Air pollution linked to higher risk of COVID-19 in young adults

22-Apr-2022 - Residential exposure to ambient air pollutants is linked to an elevated risk of SARS-CoV-2 infection, an observational study of young adults in Stockholm, Sweden shows. The study was conducted by researchers from Karolinska Institutet and is published in JAMA Network Open. Since pollutants in ...

COVID-19: Vaccination greatly reduces infectious viral load

By comparing the infectious viral load, scientists from UNIGE and HUG highlight the benefits of vaccination

21-Apr-2022 - The diagnosis of COVID-19 consists of a PCR test performed on a nasopharyngeal or salivary swab. “This test is very effective in identifying infected people, but does not indicate whether they are infectious, that is, capable of transmitting the virus to other people,” says Isabella Eckerle, ...

Technology transfer award for PCR rapid test device for infection diagnostics

In-vitro-Diagnostic company Spindiag, a University of Freiburg and Hahn-Schickard spin-off, has been recognized for its research-based development

19-Apr-2022 - Spindiag GmbH, together with the University of Freiburg and the Hahn-Schickard-Gesellschaft für angewandte Forschung e.V., was awarded the Technology Transfer Prize 2020 from the German Physical Society (DPG) on April 09, 2022 for the development of the PCR-based rapid test system Rhonda. The ...

analytica 2022: Fighting COVID-19 with combined expertise

New tools in virus research and detection

22-Mar-2022 - Whether PCR apps or high-tech analysis equipment for vaccine development: during the pandemic, the chemical analysis and biotech sector has demonstrated its strength. From June 21 to 24, 2022, the industry will come together in Munich at analytica, the leading trade fair for analysis, laboratory ...

Point-of-care diagnostics for multiple diseases, courtesy of photonics technology

New generation of diagnostic systems

21-Mar-2022 - COVID 19 has turned PCR and other antigen tests from tools known only to medical professionals into an everyday experience for all of us. To mark the successful completion of their research on the PoC-BoSens platform, the project consortium led by Fraunhofer IZM can announce the birth of a new ...

Life-science start-up Actome and QIAGEN announce commercial partnership

Licensing and co-marketing agreement signed

11-Jan-2022 - Actome GmbH, a life-science start-up company from the University of Freiburg and Hahn-Schickard, Germany has signed a license agreement and a co-marketing agreement with QIAGEN GmbH, Hilden, Germany, to jointly accelerate the market entry of Actome’s Protein-Interaction-Coupling (PICO) ...